| ||
|
|
|
| Catalog No. | Product Name | CAS No. |
| AZT01 | Aztreonam | 78110-38-0 |
| CSF02 | Caspofungin Acetate | 179463-17-3 |
| CCL01 | Cefaclor | 70356-03-5 |
| CMD03 | Cefamandole Nafate | 42540-40-9 |
| CZL02 | Cefazolin Sodium | 27164-46-1 |
| CPM01 | Cefepime HCI | 123171-59-5 |
| CXM01 | Cefixime | 79350-37-1 |
| CMZ02 | Cefmetazole Sodium | 56796-39-5 |
| CTX02 | Cefotaxime Sodium | 64485-93-4 |
| CXT02 | Cefoxitin Sodium | 33564-30-6 |
| CSL02 | Cefsulodin Sodium | 52152-93-9 |
| CTF02 | Ceftiofur Sodium | 104010-37-9 |
| CRX02 | Cefuroxime Sodium | 56238-63-2 |
| CVL01 | Clavulanate Potassium | 61177-45-5 |
| DPT01 | Daptomycin | 103060-53-3 |
| DRP01 | Doripenem | 148016-81-3 |
| ADF02 | Echinocandin B | 54651-05-7; 63035-07-4 |
| ETP02 | Ertapenem Sodium | 153832-38-3 |
| FRP02 | Faropenem Sodium | 122547-49-3 |
| FFM01 | Fosfomycin Trometamol | 78964-85-9 |
| FSD02 | Fusidate Sodium (" Fusidic Acid Sodium Salt ") | 751-94-0 |
| IMP02 | Imipenem with Cilastatin Sodium | 85960-17-4 |
| MRP01 | Meropenem Trihydrate | 119478-56-7 |
| MCF02 | Micafungin Sodium (" FK463 ") | 208538-73-2 ] |
| MNC02 | Minocycline HCl | 13614-98-7 |
| MPR01 | Mupirocin | 12650-69-0 |
| MPR02 | Mupirocin Calcium | 115074-43-6 |
| NFT01 | Nifuratel | 4936-47-4 |
| MCF04 | Pneumocandin A0 (" L-671329 ") | 539823-80-8 |
| CSF03 | Pneumocandin B0 (" L-688786 ") | 135575-42-7 |
| PSM01 | Pristinamycin IA | 3131-03-1 |
| PSM03 | Pristinamycin IIA | 21411-53-0 |
| TCP01 | Teicoplanin | 61036-64-4 |
| VCM01 | Vancomycin HCl | 1404-93-9 |
| VGM01 | Virginiamycin | 11006-76-1 |
| MCF03 | WF11899A (" FR901379 ") | N/A |
|
Patented products are only available for R&D use as permitted under CFR 35 Section 271(e)(1). Copyright © 2005 All Rights Reserved. MOLCAN CORPORATION, Canada, Tel. 905-731-5537, Fax 905-248-3843, E-Mail: contact@molcan.com |